ATP ) channels and PKC to confer cytoprotection against necrotic and apoptotic cell injury. However, the molecular structure of mitoK ATP channels remains unresolved, and the mitochondrial phosphoprotein(s) that mediate cytoprotection by PKC remain to be determined. As mice deficient in the main sarcolemmal gap junction protein connexin 43 (Cx43) lack this cytoprotection, we set out to investigate a possible link among mitochondrial Cx43, mitoK ATP channel function, and PKC activation. By patch-clamping the inner membrane of subsarcolemmal murine cardiac mitochondria, we found that genetic Cx43 deficiency, pharmacological connexin inhibition by carbenoxolone, and Cx43 blockade by the mimetic peptide 43 GAP27 each substantially reduced diazoxide-mediated stimulation of mitoK ATP channels. Suppression of mitochondrial Cx43 inhibited mitoK ATP channel activation by
Introduction
Ischemic injury can result in cell death and irreversible loss of function in a variety of biological systems (1, 2) . Understanding of the intracellular signaling mechanisms by which cells protect themselves against ischemia-induced damage bears great clinical significance with respect to the treatment and prevention of tissue injury (3) . A powerful cytoprotective adaptation can be produced by brief episodes of ischemia followed by reperfusion before sustained ischemia or by pharmacological agents such as diazoxide mimicking these preconditioning effects (1, 2) . Ischemic preconditioning (IP) leads to release of hormones or agonists that bind to G protein-coupled receptors and activate signaling pathways (1, 4) . Mitochondria are essential targets and effectors in these cytoprotective cascades (1, 5) . Particularly, it has been suggested that opening of the mitochondrial adenosine triphosphate-sensitive K + (mitoK ATP ) channel and activation of cytosolic and mitochondrial protein kinase C (PKCε) play a critical role in protection against ischemic cell injury (1, 6, 7). However, the molecular structure of mitoK ATP channels remains unresolved, and no mitochondrial phosphoprotein has yet been identified that may mediate cytoprotection by these kinases (6, 8) .
Cytoprotection by both pharmacological and IP is abolished in transgenic animals with connexin 43 deficiency (9) (10) (11) . Connexin 43 (Cx43), the main gap junction protein, is predominantly localized in the sarcolemma but is also found in the inner mitochondrial membrane ( Figure 1 ) (10, 12) . To determine how mitochondrial Cx43 might be involved in the preconditioning pathway, we used direct single-channel patch-clamp recordings of cardiac mitoplasts to identify a possible link among mitoK ATP channel function, mitochondrial Cx43, and PKC activation. dent activation or run-down (continuous 9-second pulse: Po,total, 0.28% ± 0.09% and 4.21% ± 0.50% at baseline and under diazoxide, respectively; n = 6). Diazoxide-stimulated mitoK ATP channel activity was inhibited by the nonselective mitoK ATP inhibitor glibenclamide (10 μM; Po,total, 0.35% ± 0.06%, n = 8) ( Figure 2A and Table 1 ), the selective mitoK ATP inhibitor 5-hydroxydecanoic acid (100 μM; Po,total 0.26% ± 0.16%, n = 6), and magnesium adenosine triphosphate (MgATP; 100 μM; Po,total 0.55% ± 0.09%, n = 5). Thus, mitoK ATP channels are present in wild-type mice and exhibit properties similar to those previously reported for rats (13, 14) .
To evaluate whether the diazoxide effect on mitoK ATP channel activity might be mediated via ROS, we (a) measured the effect of diazoxide on mitochondrial H 2 O 2 production by the Amplex UltraRed assay (15) ; and (b) performed mitoK ATP channel recordings in the presence of the ROS scavenger N-acetyl-l-cysteine (L-NAC) (16, 17) . While antimycin A (4 μg/ml), which stimulates ROS formation by inhibiting respiratory complex III, increased the slope of the Amplex UltraRed fluorescence in both mitochondria and mitoplasts; neither the solvent DMSO nor diazoxide (200 μM) altered Amplex UltraRed fluorescence in mitoplasts maintained in our patch-clamp solution ( Figure 2 , E and F), supporting the hypothesis that under our experimental conditions, diazoxide had no relevant unspecific effect on mitochondrial ROS production (18) . Moreover, the ROS scavenger
Figure 1
Cx43 is present in isolated subsarcolemmal mitoplasts. Mitochondria were prepared by differential centrifugation as described in Methods. An equal amount of protein (30 μg) from distinct isolation fractions -i.e., crude homogenate of isolated myocytes (TP), first pellet with cell debris (P1, discarded), second pellet containing mitochondria (P2), second supernatant (S2, discarded), intact mitochondria (P3), mitoplasts (Mitopl) -was loaded in each lane, and proteins were analyzed by immunoblotting. Immunoreactivity to the following proteins served as markers for cellular compartments: GAPDH (cytosolic marker), Na + /K + -ATPase (plasma membrane marker), SERCA2A (endoplasmic reticulum marker), VDAC (outer mitochondrial membrane marker), UCP2 (inner mitochondrial membrane marker).
L-NAC (5 mM) did no alter baseline mitoK ATP channel properties and, notably, did not attenuate diazoxide-induced mitoK ATP channel activation (Figure 2 , C and D, and Table 1 ), indicating that the stimulation of mitoK ATP channels by diazoxide is not mediated through ROS.
Since Cx43 is found in the inner mitochondrial membrane (Figure 1) (10, 12) and ischemic or pharmacological preconditioning is undermined by Cx43 deficiency independent of cell-cell coupling by gap junctions (11), we aimed to determine whether mitochondrial Cx43 might be an essential molecular component of the
Figure 2
MitoKATP single-channel activation by diazoxide (100 μM) is independent of ROS. (A) Baseline (left) and diazoxide-activated (middle) mitoKATP currents of wild-type mice in mitoplast-attached configuration at -60 mV, which was blocked by 10 μM glibenclamide (right). (B) Amplitude histogram of mitoKATP current under baseline conditions revealed a mean Iunitary of -0.83 ± 0.05 pA (n = 22). Vm, membrane voltage. (C) Single-channel amplitude (I) as a function of test potentials. Slope conductances determined by linear regression in individual experiments on wild-type mice were unaffected by the ROS scavenger L-NAC (5 mM) with or without diazoxide and with or without MgATP (100 μM) compared with control (see Figure 3B ). (D) Baseline single-channel properties (left), the diazoxide effect on mitoKATP channel activity (middle), and channel inhibition by MgATP (right) (at -60 mV) were unaffected by L-NAC compared with control (A). (E) Slope of Amplex UltraRed fluorescence of intact mitochondria (10 μg protein) in incubation buffer was significantly increased by the addition of antimycin A; n = 6, *P < 0.05 versus control. (F) Slope of Amplex UltraRed fluorescence of mitoplasts (50 μg protein) in patch-clamp buffer was increased by antimycin A but remained unchanged upon addition of the solvent DMSO or diazoxide; n = 6, *P < 0.05 versus control.
Figure 3
MitoKATP single-channel activation by diazoxide (100 μM) is dependent on the presence of mitochondrial Cx43. (A) The diazoxide effect on mitoKATP channel activity (at -60 mV) was reduced in wild-type mice by carbenoxolone (10 μM) (upper left) and 43 conducting pore of mitoK ATP channels or might transfer cytoprotective signaling to these channels. To define the role of mitochondrial Cx43, we used 4 complementary approaches, i.e., single-channel recordings of: wild-type mitoplasts in the presence of (a) the connexin inhibitor carbenoxolone (10 μM) (19) (Figure 3 , A-E, and Tables 1-3), indicating that the effect of diazoxide on mitoK ATP channels is mediated via Cx43. This notion was further supported by an additive effect of 43 GAP27 with the genetic Cx43 knockdown, i.e., the Cx43 mimetic peptide abolished diazoxide-mediated K ATP channel activation in Cx43 +/-mice ( Figure 3C and Table 2 ). Inhibition of mitoK ATP channels by MgATP (Cx43 +/-Po,total, 0.27% ± 0.09%, n = 4) and glibenclamide was retained in the presence of carbenoxolone or 43 GAP27 in Cx43 +/-mice and in Cx43 Cre-ER(T)/fl + 4-OHT mice ( Figure 3D and Tables 1-3) .
To test whether diazoxide sensitivity of mitoK ATP channels might be rescued by an increased mitochondrial Cx43 content in heterozygous Cx43 +/-mice, we compared Cx43 protein levels and diazoxide-induced mitoK ATP channel activation in mitochondria from the anterior myocardial wall (AW) subjected to IP (by 10 minutes ischemia and 10 minutes reperfusion) with mitochondria from the posterior myocardial wall (PW; no IP) of the same animals. Consistent with previous reports, IP increased mitochondrial Cx43 levels in the AW versus PW ( Figure 4A ) (10) , which was accompanied by significantly more pronounced diazoxidemediated mitoK ATP channel stimulation (Figure 4 , B-E), further supporting the hypothesis that Cx43 affects druginduced mitoK ATP channel activity.
Activation of PKCε was implicated in cytoprotection conferred by stimulating G protein-linked receptors, because direct activation of the kinase could mimic preconditioning and inhibitors eliminated protection induced by receptor stimulation (22) . Given that sarcolemmal Cx43 is a target of PKCε (23) and PKCε is constitutively localized in mitochondria (24), we reasoned that mitoK ATP channels might be activated by mitochondrial PKCε and that this effect might be mediated by mitochondrial Cx43. Thus, we analyzed the effect of PKC activation by PMA (2 μM) and the selective PKCε peptide agonist ψε receptor for activated C kinase (ψεRACK) (0.5 μM) on mitoK ATP singlechannels in wild-type and Cx43 +/-mice. The PKC activa- Table 1 Gating parameters of mitoK ATP channels and effects of diazoxide, L-NAC, glibenclamide, and MgATP on mitoK tor PMA but not its inactive analog 4α-PMA (2 μM) significantly increased mitoK ATP channel activity ( Figure 5 , A and B, and Figure 5 , A, B, D, and E, and Table 4 ). Moreover, Western blot analysis revealed enhanced phosphorylation of Cx43 at the PKC phosphorylation site Ser368 in mitochondria stimulated with ψεRACK (5 μM) versus control ( Figure 4 , F-H), consistent with the notion that Cx43 phosphorylation by PKCε serves to facilitate cytoprotective signal transduction to mitoK ATP channels. To further support the interaction of mitochondrial Cx43 and PKCε, we sought to determine whether these two proteins might associate in mitochondrial protein complexes. Immunoprecipitation of Cx43 from isolated mitochondria revealed a signal for PKCε, while immunoprecipitation of PKCε also showed a signal for Cx43 ( Figure 5C ), indicating a close association of the two proteins. The use of anti-rabbit IgGs for immunoprecipitation did not indicate a coprecipitation of one of the analyzed proteins, excluding unspecific effects. In cardiomyocytes, two mitochondrial populations exist, i.e., subsarcolemmal mitochondria located beneath the plasma membrane and interfibrillar mitochondria found between myofibrils (25) . Recently, interfibrillar mitochondria were shown not to contain any detectable Cx43 (12) . Given our observations that Cx43 transfers cytoprotective signaling to mitoK ATP channels, we therefore reasoned that drug- and PKCmediated mitoK ATP channel stimulation might be restricted to subsarcolemmal mitochondria. Thus, we evaluated mitoK ATP channel characteristics and responsiveness in isolated interfibrillar mitochondria of wild-type mice. MitoK ATP currents could be recorded in interfibrillar mitoplasts with single-channel properties similar to those of subsarcolemmal mitochondria ( Figure 6 , A-E). However, single-channel activity of mito-K ATP in interfibrillar mitoplasts was completely insensitive to PKC activation by both PMA and diazoxide ( Figure 6 , A, B, and D). Importantly, baseline activity was inhibited by MgATP and glibenclamide, thus confirming mitoK ATP channel identity ( Figure 6 , A, B, and D). The absence of mitoK ATP channel responsiveness to PKC and diazoxide stimulation in interfibrillar mitochondria further confirmed the fundamental role of Cx43 for mitoK ATP channel activation and indicates functional compartmentation of mitochondria in cell signaling.
Discussion
Cell protection involves activation of endogenous signaling, which can confer significant resistance to oxidant and other stresses associated with hypoxia/reoxygenation, thus promoting enhanced capacity for cell survival (1-3). Although mito-K ATP channels have convincingly been demonstrated to serve as central effectors of diverse upstream cytoprotective signaling pathways, the actual mitochondrial proteins involved in this process are unknown (1, 5, 6, 8) . Our results provide the first functional evidence to our knowledge of a mitoK ATP channel complex in native mitochondria by linking Cx43 to mitoK ATP channel opening. While purification of mitochondrial proteins and subsequent reconstitution in artificial lipid bilayers or pro- Table 2 Gating parameters of mitoK ATP channels and effect of the Cx43 mimetic peptide 43 GAP27 (250 μM) on mitoK ATP single-channel behavior in wild-type and teosomes suggested that mitoK ATP channels are incorporated in a multiprotein complex (26, 27) , this process may be compromised by unspecific contamination, and protein association does not necessarily reflect functional interaction in native tissue. Moreover, specification of copurified proteins was largely based on immunoreactivity without detailed proteomic analysis, which bears the uncertainty of false-positive antibody cross-binding to unrelated proteins (8, 27) . In the present study, we aimed to circumvent these limitations and show in isolated mitoplasts by a pharmacological, a peptide mimetic, and a genetic approach that Cx43 plays a key role in diazoxide- and PKC-induced mitoK ATP channel stimulation, thus defining what we believe to be a novel functional role for Cx43. Beyond cell-cell coupling, connexin hexamers, monomers, and C-terminal fragments are involved in cell signaling (28, 29) . Our observation that carbenoxolone, which inhibits gap junctions and connexin hexamers (19) , suppressed mitoK ATP channel activation similarly to genetic Cx43 deficiency suggests that Cx43 in mitochondria forms hemichannels. While such hemichannels may conduct potassium and may be modulated by ATP (30) , the presence of mitoK ATP channels in interfibrillar mitochondria lacking Cx43 argues against the notion that Cx43 builds the conduction pore of mitoK ATP channels. Existence of a channel pore that is distinct from Cx43 is further supported by the lower single-channel conductance of mitoK ATP channels than reported for full and subconductance states of connexons and gap junctions (31) . Rather, our results demonstrate that Cx43 is essential for cytoprotective signal transduction on mitoK ATP channels, which is supported 7-fold, i.e., by reduced responsiveness of these channels in the presence of (a) pharmacological Cx43 inhibition, (b) Cx43 mimetic peptides, (c) genetic heterozygous Cx43 suppression, (d) almost complete Cx43 reduction in conditional genetic Cx43 knockdown mice, (e) additive effects of 43 GAP27 with the genetic Cx43 +/-suppression, (f) rescue of diazoxide sensitivity in Cx43 +/-mice upon IP-induced Cx43 increase, and (g) absence of diazoxide/PKC response in interfibrillar mitochondria lacking Cx43.
In vivo and single-cell studies showed that both Cx43 and PKCε translocate to mitochondria during IP and are pivotal components of preconditioning (7, 10, 22) . While the present experiments confirm an IP-mediated increase in mitochondrial Cx43, our results now in addition provide a functional link between these two proteins, with PKCε phosphorylating mitochondrial Cx43 in vitro and being upstream of Cx43 in cytoprotective signal cascades. Although our experiments may not discriminate whether IP and PKCε induce stimulation of mitoK ATP channels through upregulation of mitochondrial Cx43 alone or additional Cx43 phosphorylation in vivo, our observation of Cx43-mediated mitoK ATP channel regulation suffices to explain previous reports of abolished pharmacological and IP and reduced formation of ROS in Cx43 +/-mice (9-11).
Emerging data indicate that localization of signaling molecules is a key component in cell function (32, 33) . Mitochondria are known to be distributed in different subcellular compartments (25) . Our data show that responsiveness to cytoprotective signal transduction via PKC and subsequently mitoK ATP channels is restricted to subsarcolemmal mitochondria, which are localized adjacent to the upstream receptors. Conversely, interfibrillar mitochondria do not seem to be involved in these cytoprotective pathways, given the observed diazoxide and PKC insensitivity of their mitoK ATP channels. Thus, our observations extend previous reports of distinct structure and biochemical properties of mitochondrial subgroups (25, 34) , now indicating that these subpopulations are assigned to distinct cellular functions and suggesting that cardiac cytoprotection via mitoK ATP channel activation is confined to a circumscribed subsarcolemmal compartment.
Understanding the mechanisms involved in cell protection enhances the expectation that one may pharmacologically intervene to block or modulate cell death. The fact that Cx43 regulates mitoK ATP channel activity in native mitochondria makes Cx43 an attractive target for drug development against ischemic injury. (35), and wild-type littermates, as indicated. More complete ablation of Cx43 was induced in adult Cx43 Cre-ER(T)/fl mice by the intraperitoneal injection of 3 mg 4-OHT once per day on 5 consecutive days as previously described (10, 21) . These animals were sacrificed at day 12 after the first injection. For control, Cx43 fl/fl mice were used (10, 21) .
Preparation of cardiomyocytes and subsarcolemmal/interfibrillar mitoplasts. Single ventricular myocytes were isolated by enzymatic digestion, as previously described (36) . Freshly isolated cardiomyocytes were used within 1-2 hours. Myocytes were labeled with Mitotracker Green (1 μM; Molecular Probes, Invitrogen) to facilitate identification of intact mitoplasts after further subcellular purification. Isolated intact subsarcolemmal mitoplasts were prepared from isolated myocytes by differential centrifugation, as previously reported (13, (37) (38) (39) . Briefly, myocytes were suspended for 30 minutes in a solution containing (in mM) 250 sucrose, 5 K-HEPES, and 1 CaCl2 to rupture the sarcolemma and spun at 1,500 g for 10 minutes. The supernatant containing the subsarcolemmal mitochondria was pelleted (8,500 g, 10 minutes, 4°C). The mitochondria were further purified by 2 additional centrifugation cycles (8,500 g, 10 minutes, 4°C) and the final pellet resuspended in K + solution (in mM: 150 KCl, 5 K-HEPES, 1 CaCl2, pH 7.2).
Isolated intact interfibrillar mitoplasts were prepared from isolated murine hearts, as previously described (12) . In brief, murine hearts were removed quickly after decapitation and were washed in buffer A (in mM: 100 KCl, 5 MgSO4, 50 3-[N-morpholino]-propanesulfonic acid (MOPS), 1 EGTA, 1 MgATP, pH 7.4). The ventricular tissue was minced in 10 ml/g buffer B (buffer A plus 0.04% BSA), homogenized in a Potter-Elvehjem grinder, and spun at 800 g for 10 minutes. The pellet containing the interfibrillar mitochondria was resuspended in buffer B, treated for 1 minute with nargase (8 U/g tissue [bacterial, type XXIV, Sigma-Aldrich]), homogenized with a Potter-Elvehjem grinder, and spun at 800 g for 10 minutes. The supernatant was further purified by an additional centrifugation cycle (8,000 g, 10 minutes, 4°C) and the final pellet resuspended in K + solution (in mM: 150 KCl, 5 K-HEPES, 1 CaCl2, pH 7.2). Mitochondria were stored at 4°C for up to 48 hours for patch-clamp experiments. Mitoplasts were prepared from intact mitochondria prior to patching or protein preparation by osmotic shock or digitonin, as previously described (14, 40) .
Single-channel recordings. All experiments were performed in the mitoplast-attached configuration of the patch-clamp technique (180 test pulses of 150-ms duration at 1.67 Hz, if not indicated otherwise; sampling frequency, 10 kHz; corner frequency, 2 kHz) with symmetrical bath and pipette solution composed of (in mM): 150 KCl, 10 K-HEPES; pH was adjusted to 7.2 with KOH, as previously described (13, 38) . Currents were recorded and digitized with an Axopatch 200B amplifier and Digidata 1200 interface (Axon Instruments) with the use of custom software (CDE-REVL-LEVL/X program, version 1.3) (41, 42) .
Single-channel analysis. Single-channel analysis was done using custom software only from 1-channel patches, as previously reported (13, 37, 43, 44) . Linear leak and capacity currents were digitally subtracted using the average currents of nonactive sweeps. For detailed gating analysis, idealized currents were analyzed in 150-ms steps (unless otherwise indicated). Active sweeps were defined as those with at least 1 opening. The open probability of active sweeps (Po,active; defined as the occupancy of the open state during active sweeps), the availability (fraction of sweeps containing at least 1 channel opening), and Ipeak (the peak ensemble Table 4 Effect of PKC stimulation with PMA (2 μM) and the epsilon-selective peptide τopen ( IP. We used the in situ mouse heart model, as described previously (45, 46) . Briefly, Cx43 +/-mice were anesthetized with pentobarbital sodium (80 mg/kg i.p.). The temperature of the animals was kept stable between 36.6 and 37.4°C using heating pads, and the electrocardiogram was monitored continuously. After intubation (polyethlene-60 tubing), the animals were ventilated with a stroke rate of 130/min and a tidal volume of 1 ml with oxygen-supplemented room air. A midline thoracotomy and pericardiotomy were performed. The left anterior descending coronary artery was occluded 2-3 mm distal to the tip of the left auricle using a 7.0 silk suture and a small tube to form a snare. After 10 minutes occlusion, the hearts were reperfused for 10 minutes. At the end of the protocol, hearts were rapidly excised, the anterior and posterior walls were separated, and mitochondria or mitoplasts were isolated as described above (n = 3).
Western blot analysis. Mitochondria were prepared as described above. Proteins were prepared from different isolation fractions (as indicated) with standard methods, as described previously (43) . Protein concentration was assayed using a commercial protein assay (BCA method, Pierce). After standard Laemmli SDS-PAGE (12%) and Western blotting (Bio-Rad Tankblot system, nitrocellulose membrane), proteins were detected using the following primary antibodies: Cx43 (1:5,000, rabbit polyclonal, ab11370, Abcam), GAPDH (1:200, rabbit polyclonal IgG, sc-25778, Santa Cruz Biotechnology Inc.), Na + /K + -ATPase (1:1,000, rabbit polyclonal IgG, no. 3010, Cell Signaling Technology Inc.), sarcoplasmic reticulum Ca 2+ pump gene 2 (SERCA2A; 1:100, goat polyclonal IgG, sc-8094, Santa Cruz Biotechnology Inc.), voltage-dependent anion channel (VDAC; 1:1,000, rabbit polyclonal IgG, no. 4866, Cell Signaling Technology Inc.), uncoupling protein 2 (UCP2; 1:100, goat polyclonal IgG, sc-6525, Santa Cruz Biotechnology Inc.), manganese superoxide dismutase (MN-SOD; 1:1,000, rabbit polyclonal IgG, Upstate), Cx43 phosphorylated at serine 368 (Cx43Ser368; 1:500, rabbit polyclonal IgG, Cell Signaling Technology Inc.), and horseradish peroxidase-coupled anti-rabbit secondary antibody (1:2,000, Sigma-Aldrich). Primary antibody incubations were performed overnight at 4°C. Immunoreactive bands were stained with ECL reagents (Amersham Pharmacia Biotech) according to the manufacturer's instructions. Densitometrical analysis of protein induction was performed using a CCD camera (Raytest) with AIDA densitometry analysis software (Raytest). Each Western blot was performed in triplicate, unless otherwise indicated. Immunoprecipitation of Cx43 with PKCε. Proteins were prepared from isolated mitochondria. Samples (500 μg of mitochondrial protein) were incubated with anti-PKCε antibody (rabbit polyclonal anti-human, 20 μg, Santa Cruz Biotechnology Inc.), anti-Cx43 antibody (rabbit polyclonal anti-rat total Cx43, 25 μg, Zytomed), or anti-rabbit IgGs before binding to protein A. The beads were washed 3 times with 0.5 ml phosphate-buffered saline. Immunoprecipitated proteins were electrophoretically separated on 10% polyacrylamide gels and subsequently transferred to nitrocel- 
